J&J Shines Spotlight On U.S. OTC Sales Growth
This article was originally published in The Tan Sheet
Executive Summary
Domestic OTC sales grow nearly 20% to $644 million as J&J remains on track to return 75% of recalled McNeil products to market. Consumer business head Sandra Peterson says the firm began breaking out OTC sales figures to single out how the business is doing.